Amgen and Arrowhead Pharmaceuticals have announced two license and collaboration agreements to develop and commercialise RNA interference (RNAi) therapies for cardiovascular disease.
Moderna Therapeutics, a clinical stage biotechnology company, has inked a long-term lease to build a state-of-the-art Good Manufacturing Practices (GMP) clinical manufacturing facility in Norwood, Mass.
Health Canada has released new guidance for industry that will help improve the safe use of health products, making product labels and packages easier for consumers and health professionals to read and understand.
University of Warwick spin-out Medherant is developing a novel transdermal drug delivery patch technology, has completed a funding round worth £1.5 million, including a direct investment of £650,000 from Mercia Technologies.
The US Food and Drug Administration (FDA) has granted approval for Shire’s Cuvitru in adult and paediatric patients two years of age and older.
In support of the President Barack Obama’s Precision Medicine Initiative, the U.S. Food and Drug Administration has issued two draft guidances that, when finalised, will provide a flexible and streamlined approach to the oversight of tests that detect medically important differences in a person’s genomic makeup.
A new medicines and pharmaceuticals wholesaler and distributor has been launched to solve difficulties faced by millions of people in Iraq in obtaining modern medicines to treat many illnesses effectively.
Yorkshire-based medical diagnostic company Abingdon Health as entered into a multi-year, global distribution agreement with electrophoresis specialist Sebia.
Janssen Biotech has announced that the U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of moderately to severely active Crohn’s disease in adults.
The US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes, Novartis has revealed.